Iganef 9mg Tablet CR
Marketer
Mediart Lifesciences Pvt Ltd
Salt Composition
Budesonide (9mg)
Overview Iganef 9mg Tablet CR
Budesonide 9mg extended-release tablets are corticosteroids indicated for moderate to severe ulcerative colitis. They reduce pain and inflammation associated with this condition. This medication may be administered with or without food; consistent daily dosing at the same time each day is crucial for optimal efficacy. Sudden cessation should be avoided without consulting your physician, as this can exacerbate symptoms. Common side effects include mood alterations and gastrointestinal discomfort. Furthermore, budesonide can impair the immune system, increasing susceptibility to infection. Report any signs of infection, like fever or pharyngitis, to your doctor immediately.
Uses of Iganef 9mg Tablet CR
Managing ulcerative colitis
Major Benefits of Iganef 9mg Tablet CR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Iganef 9mg Controlled-Release Tablet may be consumed with or without food, although consistent timing is recommended.
Common Side effects of Iganef 9mg Tablet CR:
- Abdominal pain
- Constipation
- Headache
- Depression
- Joint pain
- Increased risk of infection
- Muscle pain
- Muscle weakness
- Muscle twitching
- Irritability
- Nausea
How to use Iganef 9mg Tablet CR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Iganef 9mg Tablet CR can be administered with or without food, though consistent timing is recommended.
How Iganef 9mg Tablet CR works:
Iganef 9mg Controlled-Release Tablets contain a steroid that inhibits the production of inflammatory mediators. This action prevents ulceration and inflammation in the lining of the large bowel (colon and rectum), thereby relieving associated pain.
SAFETY ADVICE
AlcoholUNSAFE
Combining Iganef 9mg Tablet CR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Iganef 9mg Tablet CR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Iganef 9mg tablet may pose a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk with the possibility of infant harm.
DrivingCONSULT YOUR DOCTOR
The effect of Iganef 9mg Tablet CR on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Use of Iganef 9mg Tablet CR in individuals with kidney disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Iganef 9mg CR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Iganef 9mg CR tablets are unsuitable for individuals with severe hepatic dysfunction due to insufficient clinical data.
What if you forget to take Iganef 9mg Tablet CR :
Should you forget a dose of Iganef 9mg CR tablet, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Iganef 9mg Tablet CR
| Label | Value |
|---|---|
| Chemical Type | Inhaled corticosteroids |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently